CSIMarket
 


Immuron Limited  (IMRN)
Other Ticker:  
 

Cumulative Immuron Limited's Quick Ratio for Trailing Twelve Months Period

IMRN's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

IMRN Quick Ratio for Trailing Twelve Months Period

(Jun 30 2021)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Jun 30 2020)
IV. Quarter
Y / Y Current Liabilities Growth 117.25 % 117.25 % 117.25 % 117.25 % -56.8 %
Y / Y Cash & cash equivalent Growth 670.57 % 670.57 % 670.57 % 670.57 % -36.51 %
Quick Ratio for Trailing Twelve Months Period 22.33 20.19 17.27 13.03 6.29
Total Ranking # 141 # # # # 113
Seq. Current Liabilities Growth 0 % 0 % 0 % 117.25 % 0 %
Seq. Cash & cash equivalent Growth 0 % 0 % 0 % 670.57 % 0 %


Quick Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Immuron Limited Cash & cash equivalent average more than doubled by 670.57 % in IV. Quarter year on year, faster than Current Liabilities, this led to increase in in Immuron Limited's Quick Ratio for Trailing Twelve Months Period to 22.33, Quick Ratio for Trailing Twelve Months Period remained below Immuron Limited average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 46 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Immuron Limited. While Quick Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from to 141.

What is Quick Ratio?
Learn more about IMRN
Quick Ratio IMRN in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 47
Sector # 69
S&P 500 # 139


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
22.33 13.81 4.28
(Jun 30 2022)   (Jun 30 2019)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2021, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Annovis Bio inc   60.71 
Genprex Inc   59.69 
Atossa Therapeutics Inc   58.15 
Edgewise Therapeutics inc.  52.55 
Sensei Biotherapeutics Inc   51.88 
Innoviva Inc   50.95 
Arena Pharmaceuticals Inc   50.69 
Reviva Pharmaceuticals Holdings Inc   49.96 
Pmv Pharmaceuticals Inc   48.86 
Verve Therapeutics Inc   48.29 
Olema Pharmaceuticals inc   48.06 
Spruce Biosciences Inc   47.94 
Janux Therapeutics Inc   42.82 
Vaccitech Plc  41.99 
Synaptogenix Inc   41.17 
Xbiotech Inc   37.83 
Reneo Pharmaceuticals Inc   35.58 
Tff Pharmaceuticals Inc   34.50 
Dyne Therapeutics Inc   34.02 
Mustang Bio inc   33.84 
Kronos Bio Inc   33.49 
Nextcure Inc   32.93 
Longboard Pharmaceuticals Inc   32.76 
Generation Bio Co   32.47 
Lexaria Bioscience Corp   32.07 
Oric Pharmaceuticals Inc   31.50 
Kinnate Biopharma Inc   30.64 
Lantern Pharma Inc   29.61 
Akouos inc   29.18 
Prometheus Biosciences Inc   28.90 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

DTEA's Profile

Stock Price

DTEA's Financials

Business Description

Fundamentals

Charts & Quotes

DTEA's News

Suppliers

DTEA's Competitors

Customers & Markets

Economic Indicators

DTEA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071